Multiple sclerosis in Isfahan, Iran

Mohammad Saadatnia1, Masoud Etemadifar, Amir Hadi Maghzi

  • 1Department of Neurology, Isfahan University of Medical Sciences, Isfahan 81744, Iran.

Abstract

Insights

This study found a higher prevalence of multiple sclerosis (MS) in Isfahan, Iran, than previously reported, with a notable female predominance. The incidence rate may be increasing, suggesting Isfahan is a medium- to high-risk area for MS.

Area of Science:

  • Neurology
  • Epidemiology
  • Public Health

Background:

  • Multiple sclerosis (MS) is a chronic neurological disease with varying prevalence worldwide.
  • Understanding regional variations in MS prevalence and incidence is crucial for public health planning and resource allocation.
  • Iran, particularly the Isfahan region, has been identified as an area requiring further epidemiological investigation for MS.

Purpose of the Study:

  • To determine the prevalence and incidence of multiple sclerosis (MS) in Isfahan, Iran.
  • To describe the clinical and demographic characteristics of MS patients in Isfahan.
  • To compare these findings with existing global and regional MS data.

Main Methods:

  • A cross-sectional study was conducted in Isfahan, Iran, from 2003 to 2006.
  • Data were collected from 1718 diagnosed MS patients registered with the Isfahan MS Society (IMSS).
  • Prevalence, incidence, age of onset, disease duration, and clinical presentations were analyzed according to McDonald's criteria.

Main Results:

  • The overall period prevalence of MS was 43.8/100,000, with a female-to-male ratio of 3.4:1.
  • The incidence rate in 2005 was 3.64/100,000, indicating a potential increase.
  • Common initial symptoms included sensory (51.7%) and visual (47.5%) disturbances; specific subgroups like early-onset, late-onset, familial, and conjugal MS were identified.

Conclusions:

  • Isfahan represents a medium- to high-risk area for MS, with prevalence rates exceeding previous estimates.
  • The observed increase in incidence may contribute to the higher prevalence.
  • Clinical and demographic features align with global trends, though some regional variations warrant further investigation.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...